Neo Ivy Capital Management »

Definium Therape shares owned by Neo Ivy Capital Management

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Neo Ivy Capital Management from 13F filings

Historical chart of Neo Ivy Capital Management investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Neo Ivy Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Neo Ivy Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 315 47.04

More positions owned by Neo Ivy Capital Management

Vulcan Materials Company (VMC)
NVIDIA Corporation (NVDA)
Archer Daniels Midland Company (ADM)
Alkermes SHS (ALKS)
Palantir Techn-a Cl A (PLTR)
Lam Research (LRCX)
Micron Technology (MU)
Apple (AAPL)
Patterson-UTI Energy (PTEN)
Ultra Clean Holdings (UCTT)
Lyft Inc-a Cl A (LYFT)
Anthem (ELV)
Simmons First -a Cl A (SFNC)
International Paper Company (IP)
AGCO Corporation (AGCO)

View all positions for Neo Ivy Capital Management

Top funds holding Definium Therape

BlackRock
venBio Select Advisor
Driehaus Capital Management
Jupiter Topco
FMR
Geode Capital Management
Henderson Group
Capital Research and Management Company - Division 3
Octagon Capital Advisors
Wellington Management Company
Deep Track Capital
State Street Corporation
Citadel Advisors
Commodore Capital
Susquehanna International

View all funds holding Definium Therape